Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.

Thorac Cancer · 2024 · PMC11128373 · PMID 38602166

Europe PMC DOI

hedged sentence

0.4900

closest p · 9.8× alpha

0.4900

boldest claim

The sentences

did not reach statistical significancep = 0.49not close (p > 0.1)

However, differences in OS did not reach statistical significance (median 33.8 vs. 24.4 months; HR: 0.78, 95% CI: 0.39–1.58, p = 0.49).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.